Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

‘Next-generation’ COVID vaccine with double protection approved as cases spike

Medical authorities have approved a new COVID vaccine for use in Australia that offers protection from two strains of the virus.

The New Daily

Experts rule out third COVID booster shot

Despite a spike in COVID-19 cases, the country's leading vaccine advisory body says Australians don't yet need a fifth dose of vaccine.

AAP

3 Dividend Stocks to Buy to Help Soothe Some of Your Pain

Although inflation eased slightly last month, the Fed has indicated that the final level of interest rates could be higher than expected. With further interest rate hikes and the possibility of a recession expected to keep the market under pressure, it could be wise to buy dividend-paying stocks Pfizer (PFE),…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

COVID-19 booster uptake remains low, despite growing evidence they’re as good as older shots

DENVER — More than two months into the campaign to get people to take updated COVID-19 boosters, only about 8% of people who are eligible have received the shot, though about 23% of those 65 and older have, according to Centers for Disease Control and Prevention estimates.

The Denver Post

Ireland has raked in billions from tech giants. But what if the golden goose flies the nest?

The republic’s welcoming corporate tax policy has been a success, but it depends heavily on just a few big names

The Guardian - UK

Could Pfizer Stock Help You Retire a Millionaire?

Leading biopharmaceutical company Pfizer’s (PFE) third-quarter results demonstrated strength across most areas of its business. Moreover, the company raised its 2022 financial guidance for revenues and adjusted EPS. Also, the company has increased its dividend for 12 consecutive years, and its annual dividend yields more than 3%. Given its solid…

StockNews.com

3 Stocks Wall Street Loves

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

European regulator recommends Pfizer's Omicron booster for children

Pfizer Inc and its partner BioNTech said on Thursday the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

Reuters

Mark Zuckerberg Takes Blame As Meta Lays Off 13% Of Workforce, Elon Musk's Tesla Stock Sale May Not Sit Well With Investors, Netflix Eyes Sports Leagues: Top Stories Wednesday, Nov. 09

Benzinga

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

Tribune News Service

Pfizer boss labels Covid a 'multibillion-dollar franchise' as vaccine cost set to soar

Chief financial officer David Denton reportedly told investors at the drug maker that he expects profits will continue to rise

Wales Online

2 Stocks to Help You Beat the Bear Market Blues

The Fed’s aggressive rate hikes to tame the stubborn inflation have led to widespread recession fears. The stock market has witnessed a significant selloff. Moreover, as the bear market seems not over yet, we think fundamentally strong dividend-paying stocks, Pfizer (PFE) and Kroger (KR), might help you beat the bear…

StockNews.com

Vulnerable Australians want access to another booster dose. Here's the state of play across the country

As COVID cases rise across the country, there are calls for additional booster doses to be made available to Australians who want it.

ABC News

Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune

While sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

New VA study finds Paxlovid may cut the risk of long COVID

For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.

The Independent UK

BioNTech earnings drop but forecast for vaccine income grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier

The Guardian - UK

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

The Independent UK

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

All the latest COVID-19 news and case numbers from around the states and territories

Here's a quick wrap of the COVID-19 news and case numbers from each Australian jurisdiction from the past week.

ABC News

A heavily armed police officer was pictured talking to a mother on the beach. But was it really in Victoria?

Weeks out from the Victorian election, a photo of an armed officer talking to a mother and children has been used to attack the state's premier. But the photo is probably from Brazil.

Reuters

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

The Independent UK

Pfizer starts early-stage trial of combined Covid and flu vaccine

The trial will look at the safety of the combined jab, how effective it is and whether patients suffer any side-effects

Wales Online

Pfizer trying a jab which protects against flu and Covid

The drug is being tested on 180 people aged 18 to 64

The Guardian - AU

New Covid variants are circulating. What do we know and will the Omicron-specific booster be effective?

WHO says the strains are not different enough to label them variants of concern but experts urge staying up to date with vaccines

Benzinga

Dow Drops Over 200 Points; Crude Oil Rises Sharply

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

1 … 33 34 35 36

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.